Skip to main content

Drugs Made In America Acquisition II Corp.

DMIIR
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002040475

No open-market purchases or sales by Drugs Made In America Acquisition II Corp. insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $3.25M in total; no superinvestor holds it.

Other share classesDMIIDMIIU

Q1 2026 vs. Q4 2025

How the institutions holding Drugs Made In America Acquisition II Corp. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of DMIIR: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders4758+11
Shares31.8M39.9M+8.15M (+25.7%)
Value$4.42M$3.19M−$1.23M (−27.8%)

New holders (15)

Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to DMIIR in Q1 2026
InstitutionSharesValue% of portfolio
MMCAP International Inc. SPC2,700,000$216.0K0.02%
Healthcare of Ontario Pension Plan Trust Fund2,000,000$160.0K0.00%
Mercuria Capital Strategies, LLC750,000$60.0K0.02%
Heights Capital Management, Inc428,784$34.3K0.01%
Rivernorth Capital Management, LLC400,000$32.0K0.00%
Kryger Capital LLC365,701$29.3K0.00%
Boothbay Fund Management, LLC269,202$21.5K0.00%
Gabelli & Co Investment Advisers, Inc.179,500$14.4K0.00%
Gabelli Funds LLC161,400$12.9K0.00%
Centiva Capital, LP100,000$8.00K0.00%
Schonfeld Strategic Advisors LLC88,527$7.08K0.00%
Virtu Financial LLC47,436$4.00K0.00%
PenderFund Capital Management Ltd.49,700$3.98K0.00%
Robinson Capital Management, LLC–$8000.00%
UBS Group AG251$200.00%

Sold out (4)

Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of DMIIR in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vivaldi Asset Management, LLC2,068,118$289.5K
Quarry LP80,900$11.3K
Harraden Circle Investments, LLC50,000$7.00K
Deltec Asset Management LLC44,500$6.23K